BACKGROUND AND PURPOSE: Alleviation of aneurysm induced mass effect has been difficult with both conventional endovascular and surgical techniques. Our aim was to study the efficacy of endovascular flow modification on aneurysm-induced mass effect and compression syndrome, as demonstrated by cross-sectional imaging studies and clinical follow-up. MATERIALS AND METHODS: Thirty aneurysms larger than 10 mm were treated by flow diversion alone and previously had undergone pre- and posttreatment cross-sectional imaging. Pretreatment MR imaging or contrast CT, follow-up angiography at 6 months, and follow-up MR imaging studies between 6 and 18 months were retrospectively analyzed. The neurologic and neuro-ophthalmologic statuses of all patients were recorded before treatment and at the time of follow-up cross-sectional imaging. RESULTS: At 6 months, 28 aneurysms were completely occluded, 1 had a neck remnant, and 1 had residual filling on angiography. Between 6 and 18 months, 3 aneurysms decreased in size and 27 completely collapsed as demonstrated on MR imaging. Before treatment, 6 patients had vision loss, 10 had double vision due to a third or sixth nerve palsy or both, and 1 had hemiparesis due to brain stem compression. On MR imaging follow-up, vision loss had either improved or resolved in all except 1 patient, double vision had resolved completely (7/10) or partially (3/10), and the patient with brain stem compression became asymptomatic. There was no bleeding observed in this series. One parent artery thrombosis resulted in a major infarct. CONCLUSIONS: Endovascular flow diversion is a highly effective technique for resolving radiologic mass effect and clinical compression syndromes.
BACKGROUND AND PURPOSE: Alleviation of aneurysm induced mass effect has been difficult with both conventional endovascular and surgical techniques. Our aim was to study the efficacy of endovascular flow modification on aneurysm-induced mass effect and compression syndrome, as demonstrated by cross-sectional imaging studies and clinical follow-up. MATERIALS AND METHODS: Thirty aneurysms larger than 10 mm were treated by flow diversion alone and previously had undergone pre- and posttreatment cross-sectional imaging. Pretreatment MR imaging or contrast CT, follow-up angiography at 6 months, and follow-up MR imaging studies between 6 and 18 months were retrospectively analyzed. The neurologic and neuro-ophthalmologic statuses of all patients were recorded before treatment and at the time of follow-up cross-sectional imaging. RESULTS: At 6 months, 28 aneurysms were completely occluded, 1 had a neck remnant, and 1 had residual filling on angiography. Between 6 and 18 months, 3 aneurysms decreased in size and 27 completely collapsed as demonstrated on MR imaging. Before treatment, 6 patients had vision loss, 10 had double vision due to a third or sixth nerve palsy or both, and 1 had hemiparesis due to brain stem compression. On MR imaging follow-up, vision loss had either improved or resolved in all except 1 patient, double vision had resolved completely (7/10) or partially (3/10), and the patient with brain stem compression became asymptomatic. There was no bleeding observed in this series. One parent artery thrombosis resulted in a major infarct. CONCLUSIONS: Endovascular flow diversion is a highly effective technique for resolving radiologic mass effect and clinical compression syndromes.
Authors: P Barzó; G Bogáts; B Babik; A Hortobágyi; E Vörös; E Nagy; Z Mencser; L Csepregi; K Mátyás; M Bodosi Journal: Orv Hetil Date: 2001-12-09 Impact factor: 0.540
Authors: Peter Vajkoczy; Miikka Korja; Marcus Czabanka; Ulf C Schneider; Michael Reinert; Martin Lehecka; Peter Schmiedek; Juha Hernesniemi; Leena Kivipelto Journal: Neurosurgery Date: 2012-01 Impact factor: 4.654
Authors: T Liebig; H Henkes; S Fischer; W Weber; E Miloslavski; W Mariushi; S Brew; D Kühne Journal: Interv Neuroradiol Date: 2004-10-22 Impact factor: 1.610
Authors: W Taki; N Sakai; I Nakahara; N Osaka; T Koshiji; K Matsuda; Y Enoki; H Kikuchi Journal: Neurol Med Chir (Tokyo) Date: 1998-11 Impact factor: 1.742
Authors: Robert J McDonald; Jennifer S McDonald; David F Kallmes; Giuseppe Lanzino; Harry J Cloft Journal: Interv Neuroradiol Date: 2015-02 Impact factor: 1.610
Authors: F Clarençon; F Di Maria; J Gabrieli; E Shotar; C Zeghal; A Nouet; J Chiras; N-A Sourour Journal: Clin Neuroradiol Date: 2015-08-07 Impact factor: 3.649
Authors: M-A Labeyrie; S Lenck; D Bresson; J-P Desilles; A Bisdorff; J-P Saint-Maurice; E Houdart Journal: AJNR Am J Neuroradiol Date: 2014-07-31 Impact factor: 3.825